Fulcrum Therapeutics, Inc. FULC
3.74
(0.05)
(1.32%)
as of 25 Sep
- Market cap
- $288.8M
- P/E
- 0.0×
Follow FULC
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
17.25 | 27.00 | 33.79 | 30.96 | |
Current Ratio |
17.70 | 27.40 | 34.33 | 31.35 | |
Net Debt/EBITDA |
9.33 | 15.77 | 15.26 | 10.96 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 0.83 | 0.99 | 0.61 | |
Capex/Depreciation |
(0.26) | (0.46) | (0.02) | 1.58 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.23) | (0.27) | (0.25) | (0.21) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.23) | (0.27) | (0.25) | (0.21) | |
Cash per Share |
3.21 | 5.56 | 4.37 | 4.18 | |
Shareholders Equity per Share |
3.17 | 5.51 | 4.37 | 4.07 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.17 | 5.51 | 4.37 | 4.07 | |
Free Cash Flow |
(14.28) | (16.96) | (18.76) | (15.70) | |
Working Capital |
194.23 | 344.43 | 328.81 | 312.55 | |
Capital Expenditures |
(0.09) | (0.16) | (0.01) | 0.34 | |
Net Current Asset Value |
189.37 | 340.20 | 325.20 | 309.60 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
3.45 | 1.38 | 1.98 | 2.59 | |
Average Assets |
246.93 | 313.50 | 294.71 | 276.40 | |
Average Common Equity |
227.83 | 296.02 | 280.89 | 262.54 |
Columns are period end dates